14 ACTUAT fluticasone furoate 0.2 MG/ACTUAT Dry Powder Inhaler [Arnuity]
- RxCUI
- 1547668
- RxNorm name
- 14 ACTUAT fluticasone furoate 0.2 MG/ACTUAT Dry Powder Inhaler [Arnuity]
- Display name
- 14 ACTUAT fluticasone furoate 0.2 MG/ACTUAT Dry Powder Inhaler [Arnuity]
- Full name
- 14 ACTUAT fluticasone furoate 0.2 MG/ACTUAT Dry Powder Inhaler [Arnuity]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:58
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Arnuity Ellipta | FLUTICASONE FUROATE | GlaxoSmithKline LLC | 50f193ee-1691-486d-9370-a664df63695c | 2023-10-18 | Warnings, Adverse reactions | 1547668 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 50f193ee-1691-486d-9370-a664df63695c | ARNUITY ELLIPTA 200 MCG/INHAL Dry Powder Inhaler, 14 Blisters [PSN] · 14 ACTUAT fluticasone furoate 0.2 MG/ACTUAT Dry Powder Inhaler [Arnuity] [SBD] · 14 ACTUAT Arnuity 0.2 MG/ACTUAT Dry Powder Inhaler [SY] | 3 | 17 | These highlights do not include all the information needed to use ARNUITY ELLIPTA safely and effectively. See full prescribing information for ARNUITY ELLIPTA. ARNUITY ELLIPTA (fluticasone furoate inhalation powder), for oral inhalation use Initial U.S. Approval: 2014 | 20231018 |